Aptamer Sciences, Inc. to Speak at ACCESS ASIA Partnering Forum

September 25, 2025 (9:30 AM CST) — We’re pleased to announce that Kwangho Kim, Manager, Business Development of Aptamer, Sciences Inc., will present at the ACCESS Asia Partnering Forum Online Showcase. ACCESS Asia builds on the success of ACCESS China, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and partners

About Aptamer Sciences, Inc.

Aptamer Sciences Inc. is a clinical-stage biopharmaceutical company and global leader in aptamer technology, advancing its proprietary Aptamer Drug Conjugate (ApDC®) platform for targeted cancer therapies. Its lead candidate, AST-201, a GPC3-targeted ApDC for HCC and NSCLC, has an IND filed in Korea and shows strong potential both as monotherapy and in combination with PD-1 inhibitors. The pipeline also includes AST-202, a CD25-targeted ApDC for hematological malignancies, and AST-203, a Trop2-targeted ApDC for pancreatic cancer, both in preclinical development.

About the Speaker

Dr. Kwangho Kim serves as Manager of Business Development at Aptamer Sciences, where he leads partnering and collaboration initiatives to drive the company’s global growth strategy. He holds a Ph.D. in Pharmacy from Chungnam National University and plays a key role in advancing Aptamer Sciences’ proprietary ApDC® platform and clinical pipeline, fostering strategic alliances that support the translation of innovative aptamer technologies into impactful therapeutic and diagnostic solutions.

About ACCESS ASIA Partnering Forum

ACCESS Asia Partnering Forum Online Showcase is scheduled to be held on September 25, 2025, 9:30 AM (China Standard Time) via Zoom.
This event will spotlight the 1st wave of 100 innovators, providing them with a global stage to showcase pipelines and connect with pharma, investors, and strategic partners worldwide.

Conference Name: ACCESS Asia Partnering Forum Online Showcase
Date & Time: September 25, 2025, 9:30 AM (China Standard Time)
View more information at: https://biotochina.org/